We will develop a protein-production technology that addresses crucial problems in biosecurity and healthcare by maximizing production and system portability while minimizing production latency and cost. Our first-generation platform would leverage cell-free protein synthesis, microfluidics, and nanostructures, providing a foundation for delivering a rapidly deployable, versatile production platform for biologic therapeutics.
Lawrence Livermore National Laboratory • 7000 East Avenue • Livermore, CA 94550
Operated by Lawrence Livermore National Security, LLC, for the Department of Energy's National Nuclear Security Administration.